A person’s microbiome can aid treatment for multiple different cancer types, allowing researchers to develop microbial tests or treatments to help support immunotherapy in the future.
A new test to help diagnose a condition that can lead to oesophageal cancer – developed by Cambridge researchers and trialled by the NHS – has reduced the need for invasive endoscopy in thousands of low-risk patients.
Professor Sir Stephen Jackson, Professor Richard Gilbertson, Professor Rebecca Fitzgerald and Professor Greg Hannon have joined forces with Cancer Research UK to call on philanthropists to help tackle the disease.
Cambridge researchers will discuss their pioneering work in cancer immunotherapy as part of a package of events at this year's Cambridge Festival focusing on cancer research.
Paediatric Cancer Programme member leads guidance on providing the best care possible for patients with a rare type of tumour affecting their ovaries, which will now be freely available to doctors all over the world.
A workshop to develop a new collaboration between patient groups at Barts Cancer Institute and the Cancer Research UK Cambridge Centre took place this week.
To mark World Cancer Day on 4 February, and its campaign to make cancer care fair and equitable, we take a look at some of the ways researchers and the planned Cambridge Cancer Research Hospital are working with communities to ‘close the cancer care gap'.